Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study
- 1 December 2017
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 70 (6) , 762-769
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant RecipientsCirculation, 2011
- The Independent Association Between Serum Uric Acid and Graft Outcomes After Kidney TransplantationTransplantation, 2010
- Association of Uric Acid With Inflammation, Progressive Renal Allograft Dysfunction and Post-Transplant Cardiovascular RiskThe American Journal of Cardiology, 2009
- Baseline Characteristics of Participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) TrialAmerican Journal of Kidney Diseases, 2009
- Hyperuricemia is Associated With the Development of the Composite Outcomes of New Cardiovascular Events and Chronic Allograft NephropathyTransplantation, 2008
- Management of Cardiovascular Disease in Renal Transplant RecipientsClinical Journal of the American Society of Nephrology, 2008
- New-Onset Gout after Kidney Transplantation: Incidence, Risk Factors and ImplicationsTransplantation, 2005
- Serum Uric Acid and Cardiovascular MortalityJAMA, 2000
- Long-term survival in renal transplant recipients with graft functionKidney International, 2000
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976